Fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in the murine genome
Open Access
- 1 March 1990
- journal article
- research article
- Published by Springer Nature in Hereditas
- Vol. 112 (1) , 77-81
- https://doi.org/10.1111/j.1601-5223.1990.tb00140.x
Abstract
The cytosine analogues 5-azacytidine and 5-azadeoxycytidine were used to induce fragile sites on mouse chromosomes. Sites of relative frequent fragility were ascertained and compared with fragile sites induced by the antimetabolites methotrexate, fluorodeoxyuridine and aphidicolin as reported previously. Considerable overlap of fragile sites induced by the very different agents is evident. Fragile sites are common to all chromosomes and most of them are susceptible to different modes of induction.This publication has 11 references indexed in Scilit:
- Fragile sites, cancer chromosome breakpoints, and oncogenes all cluster in light G bandsCancer Genetics and Cytogenetics, 1988
- Fragile sites induced by FUdR, caffeine, and aphidicolinHuman Genetics, 1988
- A comparative mapping study of fragile sites in the human and murine genomesHuman Genetics, 1987
- Chromosome maps of man and mouse, IIIGenomics, 1987
- High Resolution of Mouse Chromosomes: Banding Conservation Between Man and MouseScience, 1986
- Chromosomal fragile sites and cancer-specific rearrangementsBlood, 1986
- Evolutionary conservation of fragile sites induced by 5-azacytidine and 5-azadeoxycytidine in man, gorilla, and chimpanzeeHuman Genetics, 1985
- Report of the committee on chromosome rearrangements in neoplasia and on fragile sitesCytogenetic and Genome Research, 1985
- 5-Azacytidine-induced undercondensations in human chromosomesHuman Genetics, 1984
- Robertsonian metacentrics in the mouseChromosoma, 1976